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Abstract
Background
Premature birth is the leading cause of neonatal death and second leading in children under
5. Information on outcomes of preterm babies surviving the early neonatal period is sparse
although it is considered a major determinant of immediate and long-term morbidity.
Methods
Systematic review of studies reporting outcomes for preterm babies in low and middle in-
come settings was conducted using electronic databases, citation tracking, expert recom-
mendations and “grey literature”. Reviewers screened titles, abstracts and articles. Data
was extracted using inclusion and exclusion criteria, study site and facilities, assessment
methods and outcomes of mortality, morbidity, growth and development. The Child Health
Epidemiology Reference Group criteria (CHERG) were used to assess quality.
Findings
Of 197 eligible publications, few (10.7%) were high quality (CHERG). The majority (83.3%)
report on the outcome of a sample of preterm babies at time of birth or admission. Only
16.0% studies report population-based data using standardised mortality definitions. In
50.5% of studies, gestational age assessment method was unclear. Only 15.8% followed-
up infants for 2 years or more. Growth was reported using standardised definitions but rec-
ommended morbidity definitions were rarely used. The criteria for assessment of neurode-
velopmental outcomes was variable with few standardised tools - Bayley II was used in
approximately 33% of studies, few studies undertook sensory assessments.
Conclusions
To determine the relative contribution of preterm birth to the burden of disease in children
and to inform the planning of healthcare interventions to address this burden, a renewed
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understanding of the assessment and documentation of outcomes for babies born preterm
is needed. More studies assessing outcomes for preterm babies who survive the immediate
newborn period are needed. More consistent use of data is vital with clear and aligned defi-
nitions of health outcomes in newborn (preterm or term) and intervention packages aimed
to save lives and improve health.
Introduction
The proportion of all deaths in children under-five years that occur in the first four weeks of
life (neonatal death) has increased from 36% in 1990 to 43% in 2011 and 75% of neonatal
deaths occur in the first week of life [1]. Of the estimated 7.6 million deaths in children under 5
years of age, an estimated 17%, are attributed to prematurity [1]. and approximately 35% are
attributed to preterm birth (before 37 completed weeks or 259 days of pregnancy) [2], making
prematurity the leading cause of neonatal death and the second leading cause of death in chil-
dren under five years old [1].
Globally, around 10–11% of all births, or an estimated 15 million births per year, are estimat-
ed to be born preterm (before 37 weeks gestation) [3,4]. The incidence of preterm birth is around
10.6% in North America and 6.2% in Europe [3]. There are fewer reliable estimates from low
and middle income settings because of uncertainty around assessment of gestational age and re-
liance on low birth weight as a proxy measure. However the incidence of preterm birth in these
settings is considerably higher with estimates of between 15 and 24% in ultrasound dated popu-
lation studies in African settings [5–8]. Although the reported rates of preterm birth are highest
in sub Saharan Africa, the highest absolute number of preterm births occurs in Asia [4].
Preterm birth accounts for more than one million neonatal deaths per year. Information on
the outcomes of babies born preterm but who survive the early neonatal period is very sparse
[9,10]. Preterm birth is considered to be a major determinant of immediate as well as long term
morbidity and is associated with growth and developmental delay. To be able to determine the
relative contribution of preterm birth to the burden of disease in children under five years and to
inform the planning of healthcare interventions to address this burden, a renewed understand-
ing of the assessment and documentation of outcomes for babies born preterm is needed [11].
We undertook a systematic review of studies which report on outcomes for babies re-
ported to be born preterm in low and middle income settings. For each study, we included
the method of assessment of prematurity and outcomes including mortality, morbidity,
growth and development.
Methods
Search strategy
A systematic search of all published literature using the following databases without language
restrictions was conducted: Pubmed, Cochrane, Scopus, Ovid SP, Embase, WHO Regional Da-
tabases, CINAHL, American Psychological Association and Google. Search terms used includ-
ed the MeSH terms and are shown below:
"Premature Birth" AND "Infant, Low Birth Weight" [MeSH] AND "Developing Countries"
[Majr] AND “Outcome studies” OR “outcome assessment” OR “outcome measures”OR
“treatment outcome” OR “outcome” OR “endpoint”
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We included the MeSH term of “low birth weight” as some papers used low birth weight as
a proxy measure for prematurity. The search was repeated using a definitive list of 150 develop-
ing countries from the International Monetary Fund’s World Economic Outlook Report [12].
Snowball searching was done to identify additional key papers missed.
Study selection. Inclusion criteria for final review were primary research articles published
after 1980 up to July 2014 which included 1) information on the follow up and any outcomes
(survival, morbidity, growth and development) of prematurely born infant in any low and mid-
dle income country (according to World Bank criteria above) and 2) longitudinal cohort stud-
ies, randomised controlled trials and cross sectional studies and 3) full text articles for
evaluation of all study components. Papers were excluded if they 1) had no information on out-
comes of preterm birth (survival, morbidity, growth and development) 2) were inadvertently
from a non-developing country setting 3) were systematic reviews with no direct data to inform
our research question and 4) were case studies.
We identified a total of 5321 titles through our searches. Two investigators screened these
by title. Of 2023 eligible papers identified after duplicates had been removed, 902 full abstracts
were then screened with 456 full text articles reviewed by the two investigators. Data items
sought were information regarding recruitment, gestational age, methods of assessing and out-
comes relating to mortality, morbidity, growth and development of infants (see S1 Dataset).
Data was then extracted into a table which was piloted and reconfigured particularly relating
the categorisation of place and time of recruitment, level of neonatal care which could be ac-
cessed and categorisation of mortality of infants (PNMR, NNMR, IMR). Where there were dis-
crepancies in assessment, a third reviewer was consulted. In total, 197 publications were
considered eligible for inclusion in this review (Fig. 1). We used the Child Health Epidemiology
Reference Group (CHERG) criteria to assess the quality of articles [13].
Results
A summary table of all included studies is provided (S1 Dataset).
Quality of articles
Papers were assessed for quality using the CHERG criteria: the majority were of low quality
(101/197, 51.3%) with 21 papers judged to be of high quality. Many were case series or small
cohort studies particularly those from neonatal facilities in low income settings. For observa-
tional studies, if the research took into account all plausible confounders, then they would
be upgraded.
Study Setting
Equal numbers were from Asia (62/197, 31.5%) and Sub-Saharan Africa (56/197, 28.4%); 32
(16.2%) papers from Latin America and the West Indies, 43 (21.8%) from the Middle East
and Eastern Europe and two reported on outcomes from multiple settings (Fig. 2). Out of
studies from a single setting, 41/197 (20%) were from a low income setting, 48/197 (24%)
from a low-middle income setting and just over half (103/197 (52%)) were from a higher
middle income setting.
The majority of studies (164/197, 83.7%) report on outcomes of a sample of babies born pre-
term and recruited into the study at the time of birth or at the time of admission to a special
care baby unit at a health facility. For the purpose of this review we have referred to these stud-
ies as ‘facility based studies’. Only 16.0% (31/197) of studies were from a community setting i.e.
babies and/or mothers not recruited at time of visit to a health care facility but from among the
general population usually at antenatal visits within a representative area serving a population.
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Two thirds of these studies (N = 22) came from low or low middle income settings. A total of
17.8% (35/197) studies reported population based data (sample size studied was all babies in
the general population studied or a representative sample of babies from the general popula-
tion) such as studies from Ghana [14,15], Nepal [16], Tanzania [17], Malawi [18] and
Fig 1. PRISMADiagram.
doi:10.1371/journal.pone.0120566.g001
Fig 2. Geographical Distribution of Included Studies.
doi:10.1371/journal.pone.0120566.g002
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Guatemala [19]. This included facility based studies from Brazil, China and Chile where it was
reported that almost all births in the area would have taken place in a hospital [20–25]. In gen-
eral, facility based studies tended to be small case control or cohort studies whereas community
based studies were often larger population based observational cohort studies.
Just over half of the facility based studies reported on babies who had been admitted to a
special/intensive care baby unit (114/197, 58.2%). This included 19 (9.7%) studies for babies
from a special care unit with no ventilation (almost all from low or low middle income settings)
and 63 (32.1%) from a neonatal intensive care unit with ventilator facilities. Papers reporting
on outcomes from settings where neonatal care (including ventilation) was available were pre-
dominantly from the high middle income countries particularly the Middle East but included
papers from Turkey, China, South Africa, Zimbabwe, India and Pakistan. In 32/114 (28.0%) of
the studies reporting on babies admitted to a baby care unit, it was not clear what type of neo-
natal care was available. Often this was labelled as “neonatal intensive care” or ‘neonatal care
facilities’ without specific description of content.
Population
The numbers of infants included in the studies varied from 10–12 in one study of outcomes of
preterm infants receiving continuous positive airway pressure (CPAP) in a neonatal intensive
care unit [26] to 2.9 million infants born in a national study of neonatal survival conducted
over 10 years in Chile [27]. The majority of papers (169/197, 86.2%) included in the review
were cohort studies. Only three studies followed up on only the preterm infants born from a
representative sample of the population [3,20,28]. More commonly, preterm infants were fol-
lowed up as part of a subset of a larger study looking at neonatal outcomes of all infants (or
those born low birth weight) in a community.
In 20% of studies, the parent cohort was identified during the antenatal period. For other
studies, preterm birth was determined at the time of birth, in the post natal period or at time of
recruitment to a newborn care facility (Fig. 3).
In the majority of studies (114/197, 58%) outcomes are reported for babies admitted to a
neonatal intensive care or special care unit (or unit named as a neonatal unit but with facilities
Fig 3. Setting and timing of recruitment for studies reporting on outcome of preterm birth in low and
middle income settings (% studies).
doi:10.1371/journal.pone.0120566.g003
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not specified). Frequently, studies reported on a subgroup that had complications such as re-
spiratory distress syndrome, intra-ventricular haemorrhage or retinopathy of prematurity.
The majority of studies were prospective but did not often include comparison groups and
were unclear about the inclusion or exclusion of twin infants, a likely confounder in studies of
outcomes of prematurity [29]. Just over a third (58/156, 37.2%) reported including twins.
Length of follow up
Length of follow up varied from only 24–72 hours [30,31] to 15 years in the recent cohort stud-
ies from Brazil, India, Philippines, South Africa, Guatemala [32,33]. In half of all studies, the
period of follow up was not clear. This includes a quarter (50/197, 25.5%) of studies with the
period of follow up defined as “until discharge” from a health care facility and 23.9% (47/197)
with no information at all provided about length of follow up. 15.8% (31/197) of studies fol-
lowed up infants for 2 years or more. One recent study reports on the long term growth, blood
glucose level and blood pressure outcomes in cohorts of children for over 15 years in Brazil,
India, Philippines, South Africa and Guatemala, demonstrating some differences in long term
height attainment of those born premature [32,33]. Two groups reported on long term cogni-
tive and educational outcomes of infants born prematurely—the group in India [34] and that
from the recent Stein paper [35].
Gestational age at birth. 51.0% (100/197) of all studies provided information on the gesta-
tional age at birth with an equal spread across income settings. The majority of studies included
all babies born at<37 weeks gestation but eight studies specifically targeted only late-preterm
infants (34+0–36+7 weeks gestation) and studied outcomes including general morbidity [35–
37], transcutaneous bilirubin [38], growth [30] neuro-behavioural outcomes [39] respiratory
outcomes with antenatal steroids [40] or surfactant therapy [41]. A total of 47 studies reported
only on babies born below 33 or 34 weeks with only a few of these concentrating on the ex-
tremely preterm [25,26,42].
A variety of criteria and methods of assessment were used to define gestational age at birth.
In approximately half the studies (99/197, 50.5%), the method of assessment was unclear. 22%
(44/197) of studies used a combination of methods with 7.2% (14/197) using a combination of
Ballard/Dubowitz and last menstrual period (LMP), 15.3% (30/197) of studies used antenatal
USS in combination with other methods—mainly LMP. USS dating has been used in some
community settings in low income settings such as Malawi, Mozambique, Tanzania and Guate-
mala [6,8,28,42,43], studies originating from bigger teaching hospitals such as those from Bra-
zil, Ghana, Zambia, India and South Africa [21,44,45] and studies where babies were recruited
at health care facilities with neonatal units in both low and middle income settings such as Tur-
key, Malaysia, Oman and Congo [46–49]. Almost a third of studies used a single method of as-
sessment to determine gestational age at birth. This consisted of: fundal height (two Malawi
studies) [18,50], the Capurro score in two South American studies [19,51], Ballard score in six
studies (6/197) [52–57] and Dubowitz score in six studies (6/197) [22,58–62]. LMP was the
only information used to estimate gestational age at birth in 22 studies (22/197). Low birth
weight was used as a proxy for prematurity in two studies [56,63].
Only eight studies consistently used USS dating of the pregnancy as the basis for calculation
of gestational age at birth [54,63], one study specifically looking at Doppler flow in an Indian
perinatal centre [64].
Mortality
59% (116/197) of studies measured survival as an outcome with 49 of these (25%) using uni-
form definitions for describing mortality rates (perinatal, early neonatal, neonatal and infant)
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PLOS ONE | DOI:10.1371/journal.pone.0120566 March 20, 2015 6 / 20
[65]. More than half of all studies (53.7%) 106/197 reported in-hospital mortality or survival
during the period of follow up ‘post discharge’. 29 studies reported mortality but never speci-
fied a time period for which survival was assessed. In many studies, no denominator was re-
ported and therefore it was unclear whether measurements were a rate (per 1000 live births) or
a percentage of the babies included in the study. This makes comparison across
studies difficult.
Out of 20 identified population based studies which reported on mortality rates, 19 reported
mortality using the internationally agreed definitions for Perinatal Mortality Rate (PNMR),
Neonatal Mortality Rate (NMR), Early and Late NMR. Data is summarised in Table 1. Almost
all of these studies came from low and low middle income settings with a few population based
studies from high middle income settings using systems for birth and death registration (stud-
ies from Chile and China). The others relied solely on follow up through the research studies,
of mothers who had attended antenatal clinic. Most studies compared preterm births with
term births. A few studies reported outcome separately by gestational age at birth
[14,15,20,27,31,66,67] and some just look at outcomes of late preterm birth or compare this to
term births [23,24,39,40].
All studies report an increased mortality rate among babies born preterm or report prema-
turity as the leading cause of death in neonates with lower gestational ages associated with
increased mortality.
Morbidity
There is currently no agreed set of criteria to define neonatal or infant morbidity. In the includ-
ed studies, morbidity was defined in a variety of ways. The Simplified Newborn Illness Severity
and Mortality Risk Score II (SNAPP II) was used in two studies from tertiary neonatal units in
Brazil [68,69].
Measures of morbidity used particularly in community based studies included; need for hos-
pitalisation and prevalence of wheezing and pneumonia [23], number of routine and additional
clinic visits in the post natal period [19] or a pictorial diary with specific measurements of diar-
rhoea and ways of measuring body temperature and respiratory rate [17]. Studies with an em-
phasis on facility based care used proxy measures for morbidity such as need for transfer to
NICU [49], length of time in NICU [70,71,72] time spent in oxygen [73] and time spent on ven-
tilator [41,74–76], number of routine and additional clinic visits in the post natal period [19].
Specific morbidities relating to preterm in neonatal intensive care units (mainly in the
higher middle income countries) used well defined criteria in some cases. For example intra-
ventricular haemorrhage [77,78] was defined using the Levene staging system [79] or the Papile
classification [80–82]. Studies looking at necrotising enterocolitis [53,81,83–88] used the Bells
(or modified Bell’s) criteria [89] and some studies [77] using the Gidieon classification for re-
spiratory distress syndrome [90] or a classification for, broncho-pulmonary dysplasia [52,91–
96]. Some studies looking at retinopathy of prematurity [75,76,92–95,98–100] used the Inter-
national Classification of Retinopathy of Prematurity (ICROP) [75,97,99–101]. These well-de-
fined outcomes tools were not however systematically used across all studies in neonatal units
which reported these morbidities.
The majority of these facility based studies report an increased risk of morbidity in preterm
infants compared to babies born at term. This includes increased risk of respiratory distress syn-
drome (RDS) [52,59,102,103], broncho-pulmonary dysplasia (BPD) [68,97,104–108], retinopa-
thy of prematurity (ROP) [73,101,106,109] intraventricular haemorrhage (IVH) [72,110],
periventricular leukomalacia (PVL) [111] and cerebral palsy [55,58,112]. Studies are however
not comparable due to differences in diagnostic approach and level of care available in the
Outcomes of Premature Infants in LMIC - What Are We Measuring?
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different settings. In addition, lack of information on the range of gestational age at birth even in
hospital populations studied makes comparison difficult. Some studies specifically looked at
morbidity in the late preterm group and report an increased risk of morbidity including hyperbi-
lirubinaemia, sepsis, wheezing and hospital admissions post discharge [23,30,35–37,39,103,113].
Growth
Less than 50% of all included studies report on growth outcomes. Where growth was reported,
it was in a mixture of both low and middle income studies, this is usually done using standard
internationally agreed methods and includes measurement of head circumference, height,
weight (and in combination) using CDC or WHO standard growth curves for comparison.
Overall studies report that babies born preterm do not meet the same growth targets as ba-
bies born at term, continue to remain below the standard growth curve and demonstrate re-
duced ability for catch up growth. This is particularly well documented in the larger
prospective community studies—almost all which had a follow up period of two years—from
Malawi [28], Tanzania [114], India [115], Pakistan (3 year follow up) [116] China [117] and
Brazil [23] as well as the more recent longer term cohort studies from India, Philippines, Brazil,
Guatemala and South Africa [33]. This demonstrated lack of complete catch up growth at 15
years in those born premature or born at term but who were small for gestational age. It also
demonstrated how those who did have catch up growth in the post natal period did make gains
in height and schooling regardless of birth status. Interestingly, the studies documenting
growth outcomes for babies who had received care in a well-equipped health care facility Coo-
per in South Africa [55] and Ho in Hong Kong [70] reported that there was less evidence of dif-
ferences in growth between babies born preterm and term. In Kenya, where neonatal special
care facilities are much more limited, only 20–28% of infants born preterm reached the lower
limit of normal growth by term [118].
Development
In total, only 38/197 (19.4%) of the studies found reported on development and/or neurological
outcomes of babies born preterm. Studies came equally from low, low middle and high middle
income settings. 5 of these studies were from neonatal intensive care units in countries such as
China, South Africa and Turkey with some of these studies examining specific cohorts of chil-
dren such as those with periventricular echogenicities [46], cord pH at birth [119], the use of
ferritin [120] or absent end diastolic flow [83]. Only five studies were population based: Malawi
[28], Pakistan [116], Ethiopia [121], Guatemala [43] and a recent large study in Nepal [16].
The majority of other studies were from babies who had been admitted to a neonatal unit in-
cluding India [34,58,122–125], Bangladesh [126], Kenya [112] and Taiwan were developmental
care was provided [97]. Outcome measures include a wide range of developmental cognitive
educational or neurological assessments (Table 2). Some studies conducted comprehensive
neurological and developmental assessments as well as vision and hearing testing
[55,93,121,126,127]. Only a few of these studies clarified criteria for neurological impairment
or cerebral palsy [93,112]. 82% (31/38) of those studies assessing development or cognition
used the Bayley Scales of Infant Development II or III with two studies using an adapted Indian
version. Other developmental tools used were the Griffiths Mental Development Scales
[54,70], the Denver II [22] or the Gesell Developmental Scales [117] (some adapted or validat-
ed for a specific setting). Some used tools created for a specific region such as the Malawi De-
velopmental Assessment Tool [128] or the Ankara Developmental Screening Inventory [129].
Some used specific tools for one area of development or ability such as the Peabody Develop-
mental Motor Scale, the Movement ABC or the Reynell Developmental Language Scales.
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Cognitive measures which were used varied and included the WISC III, WISC-R Bender Ge-
stalt and Human figure drawing tests, WAIS, Kaufman ABC and the Stanford Binet. Beha-
vioural measures were used in a minority of studies and included the Achenbach
questionnaires and Raval’s scales of social maturity. Neurological assessments were conducted
in a few studies with some using specific classification systems such as those by Costello [130],
Robertson [131], Saigal and Rosenbaum [132] or Amiel-Tison and Gosselin [133].
Although studies varied in terms of outcomes and are difficult to compare, generally there
were poorer developmental outcomes in babies born preterm compared to term.
Discussion
Prematurity is the leading cause of neonatal mortality worldwide and one of the limiting fac-
tors for achieving a two thirds reduction in under five mortality rate between 1990 and 2015
(Millennium Development Goal 4) [134].
Alongside this, reports of a very high incidence of prematurity from reliable studies in low
and middle income settings (with good estimates of gestational age at delivery and representa-
tive population samples) are now emerging.
This review identified almost 200 studies which report on outcome for babies born preterm.
Studies represent a good geographical spread. Very few studies are from a community setting
or provide population based data; most studies report outcomes for babies born in a health
care facility and/or accessing health care because of identified health problems associated with
preterm birth. With an estimated 47% of babies born with skilled birth attendance in low in-
come countries and 60% in lower middle income countries [1] this means that there is current-
ly no information about the majority of babies born preterm who have no access to health care
and for whom outcomes might be worse than those reported in this review. Even for those
where health care was available, the outcome for babies born preterm will depend on the avail-
ability and uptake of newborn care. In almost 30% of all studies reporting on babies who had
received care at a ‘baby care unit’ there was no information about the level of clinical care and
in many more cases, the information was inferred by reading the article carefully rather than it
being reported clearly within the text.
We noted considerable variation in recruitment of participants, location of study, method
of assessing gestational age and whether still births were included in the figures. Another key
determinant of survival for babies born preterm is gestational age at time of birth. Only 51% of
studies reported on the gestational ages of the infants. Furthermore the actual method of as-
sessment was not clear in fifty percent of the studies. Gestational age, where reported, was most
frequently estimated only after birth via assessment of appearance of the baby with/ without
taking into account recall of the date of the last menstrual period. Only eight studies consistent-
ly used ultrasound scan dating.
For studies reporting ‘mortality rates’ both the denominator and nominator were not clear
and did not fit with standard definitions, for example, perinatal, early neonatal, late neonatal or
infant mortality. After extensive examination of the data it became clear that comparison of
these data and conduct of a meta-analysis is currently not possible. A recent paper published
by Katz includes a meta-analysis from original datasets obtained specifically for this purpose.
This study does provide pooled overall relative risks for preterm neonatal mortality at 6.82 and
2.50 for post neonatal mortality with higher rates for those born both preterm and small for
gestational age (SGA) 15.42 [135]. Similarly in studies we identified in this systematic review
mortality rates are consistently higher in preterm births than in term births.
There are no currently agreed standard criteria to capture neonatal morbidity. In this sys-
tematic review, key morbidities in facilities in low and middle income settings do not seem to
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be dissimilar from those seen in high income settings [136]. Tools used for measuring neonatal
morbidity in neonatal units such as the SNAPPE II [137] uses physiological indicators which
cannot be feasibly obtained in most low income settings. Some standard definitions for mor-
bidities such as intraventricular haemorrhage or retinopathy or prematurity are present but are
not useful in community settings where little facilities are present for diagnoses. Some studies
used criteria for assessing sepsis. None of these were defined according to internationally rec-
ognised criteria. However, it is likely that some are similar to that defined in the Young Infants
Clinical Signs Study [138] which could be used more frequently. In contrast, growth was as-
sessed using comparable criteria across the majority of studies. Similar to high income settings,
growth falters with inadequate feeding in the preterm period.
The assessment of neuro-developmental outcomes was extremely variable with a variety of
tools measuring a range of domains of neurodevelopment including general development, spe-
cific cognitive outcomes, physical examination measurements or specific sensory outcomes.
Apart from growth as an outcome, there are no standard definitions for criteria for morbidi-
ty and development and even though there are standard definitions for mortality, these are
often not used.
This review has highlighted the need for more robust studies assessing the outcomes for ba-
bies born preterm but who survive the immediate newborn period. It is vital that more consis-
tent use of data is encouraged with clear and aligned definitions of both health outcomes in the
newborn (preterm or term) and the intervention packages aimed to save lives and improve
health. Methods of gestational age assessment, care packages available and outcomes to be as-
sessed will need to be clearly defined and standardised to truly measure the burden of disease
associated with preterm birth as well as to assess the effect of interventions to prevent or reduce
morbidity and developmental delay in babies who survive. Similar to the call for core outcome
indicators for trials [139] and the CROWN initiative [140] asking for core outcome measures
in Women’s Health, we would recommend the development and adaptation of an agreed
framework and indicators for the reporting of outcomes following preterm birth (Fig. 4). With
the global burden of disease pertaining not only to mortality but also to morbidity, it is impor-
tant that indicators assess these outcomes as well. Without this we will continue to lack the evi-
dence needed to decide which interventions are most effective to improve outcomes for the
large number of preterm babies born in low and middle income countries.
Fig 4. Recommended reported measures for studies on neonatal outcomes.
doi:10.1371/journal.pone.0120566.g004
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